Stock Picking ๐ Diversification: No more than 5% of your capital in a single share #stockmarket #...
44Stock Picking ๐ Diversification: No more than 5% of your capital in a single share
๐ ๏ธ Interview with Eric LEWIN, President of EL Consulting, Municipal Councilor of Neuilly-sur-Seine, Consultant @BFMBusiness @PublicationsagoraFrance @TVFinance @radioclassiqueradio:https://www.linkedin.com/in/eric-olivier-lewin-b3a94359/ย
๐ Discover the book "13 Capital Tips for Surviving the Stock Market" @Lextenso:https://www.lgdj.fr/13-conseils-capitaux-pour-survivre-en-bourse-9782297282949.html.
๐ Also find Eric in Marchรฉs en Apartรฉ, a book (collection of interviews) co-written by Fabien LABROUSSE (Founder of VideoBourse) and Benoit FERNANDEZ-RIOU @Lextenso :https://amzn.to/4iGhQDVV
#stockpicking #stockpicks #diversification #indices #smallcaps #trading #moneymanagement #riskmanagement #risk #stocks #volatility #nasdaq #sp500 #forex #dax #lvmh #apple #eurusd #euronext #bfmbusiness #ethereum #crypto #bitcoin #finance #financialmarkets #etf #futures #options #derivatives #midcap #investing #investment #broker #banks #speculation #startup #bonds #commodities #boursorama #prorealtime #tradingview #metatrader #money #business #trump #swingtrading #pea #cto #degiro #traderepublic #vix #xtb #biotech #turbos #warrants #cfd #nanobiotix #pharnext #liquidation #drug #health #pharmaceutical #laboratory #medicine #research #lab
"I'm all for spiel, for speculation, provided you're good at it, but never put more than 5% in. Roughly speaking... I prefer someone with 20 lines of 5% rather than 30% on one line. I don't like leveraged products (turbos, warrants, CFDs, all these products...) well, there are very, very few of them in the world of small caps so we are not affected by that but I think that you have to diversify your portfolio and diversify your sector, that is to say that roughly I think that you shouldn't really put all your eggs in one basket, there are two sectors on which I am quite doubtful: biotechs, I really advise against having them, every time I wanted to do it I made a mistake, I remember that Nanobiotix was supposed to be a revolution, the share price collapsed... At the beginning I believed in Pharnext, the share price ended up in liquidation... So I think that you really shouldn't do this sector which is too dangerous, that's what I say in my book: there is a chapter on it, to the extent that companies when they come to the stock market and they are biotechs they come 10 years before the launch of the drug..."